NMR mapping of the antigenic determinant recognized by an anti-gp120, human immunodeficiency virus neutralizing antibody.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  European Journal of Biochemistry

• Publication date

  1995-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1111/J.1432-1033.1995.0178L.XPMID 7538073
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structural evidence for induced fit as a mechanism for antibody-antigen recognition.

  1994cited by this paper
• Biospecific interaction analysis using biosensor technology

  1993cited by this paper
• Broadly neutralizing monoclonal antibodies to the V3 region of HIV-1 can be elicited by peptide immunization.

  1993cited by this paper
• Measurement of kinetic binding constants of viral antibodies using a new biosensor technology.

  1993cited by this paper
• Antigen-antibody binding and mass transport by convection and diffusion to a surface: a two-dimensional computer model of binding and dissociation kinetics.

  1993cited by this paper
• Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigen.

  1993cited by this paper
• A T1 rho-filtered two-dimensional transferred NOE spectrum for studying antibody interactions with peptide antigens.

  1993cited by this paper
• Characterization of a mouse/human chimeric monoclonal antibody (C beta 1) to a principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.

  1992cited by this paper
• Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody

  1992cited by this paper
• Solution conformation of a peptide corresponding to the principal neutralizing determinant of HIV-1IIIB: a two-dimensional NMR study.

  1992cited by this paper
• Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins.

  1992cited by this paper
• Characterization of a Mouse/Human Chimeric Monoclonal Antibody (Cβ1) to a Principal Neutralizing Domain of the Human Immunodeficiency Virus Type 1 Envelope Protein

  1992cited by this paper
• Induced peptide conformations in different antibody complexes: molecular modeling of the three-dimensional structure of peptide-antibody complexes using NMR-derived distance restraints.

  1992cited by this paper
• Conformation and dynamics of an Fab'-bound peptide by isotope-edited NMR spectroscopy.

  1992cited by this paper
• Crystal structures of an antibody to a peptide and its complex with peptide antigen at 2.8 A.

  1992cited by this paper
• Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody.

  1992cited by this paper
• Antigen mobility in the combining site of an anti-peptide antibody.

  1991cited by this paper
• Prediction of optimal peptide mixtures to induce broadly neutralizing antibodies to human immunodeficiency virus type 1.

  1991cited by this paper
• 2.9 A resolution structure of an anti-dinitrophenyl-spin-label monoclonal antibody Fab fragment with bound hapten.

  1991cited by this paper
• Solution conformational preferences of immunogenic peptides derived from the principal neutralizing determinant of the HIV-1 envelope glycoprotein gp120.

  1991cited by this paper
• A novel hydrogel matrix on gold surfaces in surface plasmon resonance sensors for fast and efficient covalent immobilization of ligands

  1990cited by this paper
• Detection of antigen—antibody interactions by surface plasmon resonance. Application to Epitope Mapping

  1990cited by this paper
• Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant.

  1990cited by this paper
• Antibodies against a peptide of cholera toxin differing in cross-reactivity with the toxin differ in their specific interactions with the peptide as observed by 1H NMR spectroscopy.

  1990cited by this paper
• Confronting the hypervariability of an immunodominant epitope eliciting virus neutralizing antibodies from the envelope glycoprotein of the human immunodeficiency virus type 1 (HIV-1).

  1990cited by this paper
• NMR-derived model for a peptide-antibody complex.

  1990cited by this paper
• Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.

  1989cited by this paper
• Conformations of immunoglobulin hypervariable regions

  1989cited by this paper
• Probing antibody diversity by 2D NMR: comparison of amino acid sequences, predicted structures, and observed antibody-antigen interactions in complexes of two antipeptide antibodies.

  1989cited by this paper
• Interactions of antibody aromatic residues with a peptide of cholera toxin observed by two-dimensional transferred nuclear Overhauser effect difference spectroscopy.

  1989cited by this paper
• Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope

  1988cited by this paper
• Differences in crystal properties and ligand affinities of an antifluorescyl fab (4‐4‐20) in two solvent systems

  1988cited by this paper
• Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120.

  1988cited by this paper
• Characteristics of a Neutralizing Monoclonal Antibody to the HIV Envelope Glycoprotein

  1988cited by this paper
• Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides.

  1988cited by this paper
• Structure of antibody hypervariable loops reproduced by a conformational search algorithm

  1988cited by this paper
• Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees.

  1988cited by this paper
• Three-dimensional structure of a complex of antibody with influenza virus neuraminidase

  1987cited by this paper
• Canonical structures for the hypervariable regions of immunoglobulins.

  1987cited by this paper
• Three-dimensional structure of an antibody-antigen complex.

  1987cited by this paper
• Three-dimensional structure of an antigen-antibody complex at 2.8 A resolution

  1986cited by this paper
• Phosphocholine binding immunoglobulin Fab McPC603. An X-ray diffraction study at 2.7 A.

  1985cited by this paper
• MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy

  1985cited by this paper
• Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of 1H-1H spin-spin coupling constants in proteins.

  1983cited by this paper
• Protein folding by restrained energy minimization and molecular dynamics.

  1983cited by this paper
• Theory and applications of the transferred nuclear overhauser effect to the study of the conformations of small ligands bound to proteins

  1982cited by this paper

• Rapid Mapping of Protein Binding Sites and Conformational Epitopes by Coupling Yeast Surface Display to Chemical Labeling and Deep Sequencing.

  2025cites this paper
• Charged Scanning Mutagenesis as a High Throughput Approach for Epitope Mapping

  2025cites this paper
• Rapid Mapping of Protein Binding Sites and Conformational Epitopes by Coupling Yeast Surface Display to Chemical Labeling and Deep Sequencing.

  2018cites this paper
• Identification of Allergenic Epitopes and Critical Amino Acids of Major Allergens in Chinese Shrimp ( Penaeus chinensis) by Immunoinformatics Coupled with Competitive-Binding Strategy.

  2018cites this paper
• Mapping Protein Binding Sites and Conformational Epitopes Using Cysteine Labeling and Yeast Surface Display.

  2017cites this paper
• An extended CCR5 ECL2 peptide forms a helix that binds HIV‐1 gp120 through non‐specific hydrophobic interactions

  2015cites this paper
• Identification of the Regions in Factor V Mediating its Edocytosis by Megakaryocytes to Form the Unique Platelet-Derived Cofactor Molecule

  2013cites this paper
• The conformation and orientation of a 27-residue CCR5 peptide in a ternary complex with HIV-1 gp120 and a CD4-mimic peptide.

  2011cites this paper
• Epitope mapping of antibody-antigen complexes by nuclear magnetic resonance spectroscopy.

  2009cites this paper
• 2D-measurement of proton T 1 ρ relaxation in unlabeled proteins: Mobility changes in α -bungarotoxin upon binding of an acetylcholine receptor peptide.

  2008cites this paper
• Conformational properties of HIV-1 gp120/V3 immunogenic domains.

  2005cites this paper
• Induced fit in HIV-neutralizing antibody complexes: evidence for alternative conformations of the gp120 V3 loop and the molecular basis for broad neutralization.

  2005cites this paper
• Display libraries on bacteriophage lambda capsid.

  2005cites this paper
• Two-dimensional measurement of proton T1rho relaxation in unlabeled proteins: mobility changes in alpha-bungarotoxin upon binding of an acetylcholine receptor peptide.

  2005cites this paper
• Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop.

  2003influential citation
• A monomeric 3(10)-helix is formed in water by a 13-residue peptide representing the neutralizing determinant of HIV-1 on gp41.

  2002cites this paper
• Expression, purification, and isotope labeling of a gp120 V3 peptide and production of a Fab from a HIV-1 neutralizing antibody for NMR studies.

  2002cites this paper
• Structure and orientation of a G protein fragment in the receptor bound state from residual dipolar couplings.

  2002cites this paper
• Effect of glycosylation on MUC1 humoral immune recognition: NMR studies of MUC1 glycopeptide-antibody interactions.

  2002cites this paper
• NMR mapping and secondary structure determination of the major acetylcholine receptor alpha-subunit determinant interacting with alpha-bungarotoxin.

  2001cites this paper
• Conformational model for the consensus V3 loop of the envelope protein gp120 of HIV-1 in a 20% trifluoroethanol/water solution.

  2001cites this paper
• A model of a gp120 V3 peptide in complex with an HIV-neutralizing antibody based on NMR and mutant cycle-derived constraints.

  2000cites this paper
• Solution Structure of an Antibody-Bound HIV-1IIIB V3 Peptide: A Cis Proline Turn Linking Two β-hairpin Strands

  2000cites this paper
• NMR structure of an anti-gp120 antibody complex with a V3 peptide reveals a surface important for co-receptor binding.

  2000cites this paper
• Interaction of a bacterially expressed peptide from the receptor binding domain of Pseudomonas aeruginosa pili strain PAK with a cross-reactive antibody: conformation of the bound peptide.

  2000cites this paper
• A cis proline turn linking two β-hairpin strands in the solution structure of an antibody-bound HIV-1IIIB V3 peptide

  1999cites this paper
• 2D-NMR and ATR-FTIR study of the structure of a cell-selective diastereomer of melittin and its orientation in phospholipids.

  1999cites this paper
• Application of NMR to Conformational Studies of an HIV Peptide Bound to a Neutralizing Antibody

  1999cites this paper
• Mapping of the minimal domain encoding a conformational epitope by lambda phage surface display: factor VIII inhibitor antibodies from haemophilia A patients.

  1999cites this paper
• The principal neutralizing determinant of HIV-1IIIB: Conformation of the peptide bound to a neutralizing antibody studied by 2D-NMR

  1998cites this paper
• Structural information on a cecropin-like synthetic peptide, Shiva-3 toxic to the sporogonic development of Plasmodium berghei.

  1998cites this paper
• Epitope mapping.

  1998cites this paper
• All-D peptides recognized by an anti-carbohydrate antibody identified from a positional scanning library.

  1998cites this paper
• Interaction of the receptor binding domains of Pseudomonas aeruginosa pili strains PAK, PAO, KB7 and P1 to a cross-reactive antibody and receptor analog: implications for synthetic vaccine design.

  1997cites this paper
• An NMR study of the interaction of 15N-labelled bradykinin with an antibody mimic of the bradykinin B2 receptor.

  1997cites this paper
• Glycosylation affects both the three-dimensional structure and antibody binding properties of the HIV-1IIIB GP120 peptide RP135.

  1997cites this paper
• NMR study of the peptide present in the principal neutralizing determinant (PND) of HIV-1 envelope glycoprotein gp120.

  1997cites this paper
• Conformation of the principal neutralizing determinant of human immunodeficiency virus type 1 in complex with an anti-gp120 virus neutralizing antibody studied by two-dimensional nuclear magnetic resonance difference spectroscopy.

  1997cites this paper
• Thermodynamic Analysis of the Interaction between the 0.5β Fv Fragment and the RP135 Peptide Antigen Derived from the V3 Loop of HIV-1 gp120*

  1997cites this paper
• NMR study and comparison of the antigenic properties of a peptide recognized by two HIV‐1 neutralizing antibodies

  1997cites this paper
• Contribution of Arginine Residues in the RP135 Peptide Derived from the V3 Loop of gp120 to Its Interaction with the Fv Fragment of the 0.5β HIV-1 Neutralizing Antibody*

  1996cites this paper
• Highly specific, cross-reactive sequences recognized by an anti-HBsAg antibody identified from a positional scanning synthetic combinatorial library.

  1996cites this paper
• Uses of biosensor technology in the development of probes for viral diagnosis.

  1996cites this paper
• Conformational preferences of a chimeric peptide HIV-1 immunogen from the C4-V3 domains of gp120 envelope protein of HIV-1 CAN0A based on solution NMR: comparison to a related immunogenic peptide from HIV-1 RF.

  1996cites this paper
• Characterization by serial deletion competition ELISAs of HIV-1 V3 loop epitopes recognized by monoclonal antibodies.

  1996cites this paper
• Structural requirements for and consequences of an antiviral porphyrin binding to the V3 loop of the human immunodeficiency virus (HIV‐1) envelope glycoprotein gp120

  1995cites this paper
• V-2 Nov 95

  year unknowncites this paper